biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > About the share price today...

<< Previous

Bullboard Posts

Next >>

Post by JDavenporton Dec 16, 2021 2:21pm

248 Views

Post# 34237832

About the share price today...

There are people who were very likely waiting for an AGM reaction before they sold BTI for a tax loss. There are only 9 trading days left this year to take that loss. However confirming the AGM is, there are still people who want to sell.

I already predicted that the post-AGM market would likely be weak.

Great buying opportunity though.

jd

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks